Explore
13D/13G Activist Filings
118,730 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | PCSC | Perceptive Capital Solutions Corp | Commodore Capital LP | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Point72 Asset Management, L.P. | 13G/A | 6.9% | 3.0M |
| Feb 17, 2026 | UONE | URBAN ONE, INC. | Citadel Securities GP LLC | 13G | 9.4% | 580K |
| Feb 17, 2026 | CMPR | CIMPRESS plc | ArrowMark Colorado Holdings, LLC | 13G/A | 3.6% | 883K |
| Feb 17, 2026 | GLTO | Galecto, Inc. | Jain Global LLC | 13G | 7.5% | 121K |
| Feb 17, 2026 | FBRX | FORTE BIOSCIENCES, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 11.4% | 1.4M |
| Feb 17, 2026 | LBRX | LB PHARMACEUTICALS INC | RA Capital Management, L.P. | 13G/A | 8.7% | 2.2M |
| Feb 17, 2026 | KOD | Kodiak Sciences Inc. | Point72 Asset Management, L.P. | 13G/A | 3.5% | 2.2M |
| Feb 17, 2026 | GIL | GILDAN ACTIVEWEAR INC | JANUS HENDERSON GROUP PLC | 13G/A | 5.7% | 10.5M |
| Feb 17, 2026 | CRML | Critical Metals Corp. | Alyeska Investment Group, L.P. | 13G | 9.9% | 11.7M |
| Feb 17, 2026 | SSNC | SS&C TECHNOLOGIES HOLDINGS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 5.7% | 14.0M |
| Feb 17, 2026 | PVLA | PALVELLA THERAPEUTICS, INC. | First Light Asset Management, LLC | 13G | 7.5% | 887K |
| Feb 17, 2026 | AVBP | ArriVent BioPharma, Inc. | INFINITUM ASSET MANAGEMENT, LLC | 13G/A | 9.9% | 4.1M |
| Feb 17, 2026 | FLEX | FLEX LTD. | JANUS HENDERSON GROUP PLC | 13G/A | 6.0% | 22.3M |
| Feb 17, 2026 | WOLF | WOLFSPEED, INC. | Point72 Asset Management, L.P. | 13G/A | 3.8% | 990K |
| Feb 17, 2026 | ALHC | Alignment Healthcare, Inc. | GENERAL ATLANTIC, L.P. | 13G/A | 6.6% | 13.2M |
| Feb 17, 2026 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 7.0% | 1.6M |
| Feb 17, 2026 | CCSI | Consensus Cloud Solutions, Inc. | ArrowMark Colorado Holdings, LLC | 13G/A | 6.2% | 1.2M |
| Feb 17, 2026 | OLMA | OLEMA PHARMACEUTICALS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 8.4% | 6.7M |
| Feb 17, 2026 | CEPT | Cantor Equity Partners II, Inc. | Alyeska Investment Group, L.P. | 13G | 7.2% | 1.8M |
| Feb 17, 2026 | TTAN | ServiceTitan, Inc. | 15 Angels II LLC | 13G/A | 0.2% | 138K |
| Feb 17, 2026 | DYN | DYNE THERAPEUTICS INC | JANUS HENDERSON GROUP PLC | 13G/A | 8.5% | 13.9M |
| Feb 17, 2026 | LNTH | LANTHEUS HOLDINGS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 8.6% | 5.7M |
| Feb 17, 2026 | ADCT | ADC Therapeutics SA | Point72 Asset Management, L.P. | 13G/A | 4.0% | 5.0M |
| Feb 17, 2026 | ORGO | Organogenesis Holdings Inc. | First Light Asset Management, LLC | 13G/A | 2.9% | 3.6M |
| Feb 17, 2026 | JANX | JANUX THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 8.9% | 5.4M |
| Feb 17, 2026 | CABA | CABALETTA BIO, INC. | Alyeska Investment Group, L.P. | 13G/A | 4.7% | 4.5M |
| Feb 17, 2026 | TARA | PROTARA THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 10.0% | 5.1M |
| Feb 17, 2026 | OMEX | ODYSSEY MARINE EXPLORATION INC | FourWorld Capital Management LLC | 13G/A | 0.8% | 456K |
| Feb 17, 2026 | MIRM | MIRUM PHARAMACEUTICALS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 11.8% | 6.1M |
| Feb 17, 2026 | VSTM | Verastem, Inc. | Point72 Asset Management, L.P. | 13G/A | 1.3% | 995K |
| Feb 17, 2026 | FULC | FULCRUM THERAPEUTICS, INC. | RA Capital Management, L.P. | 13G/A | 9.9% | 6.6M |
| Feb 17, 2026 | TERN | Terns Pharmaceuticals, Inc. | Commodore Capital LP | 13G/A | 1.4% | 1.5M |
| Feb 17, 2026 | PLRX | PLIANT THERAPEUTICS, INC. | Point72 Asset Management, L.P. | 13G/A | 0.1% | 47K |
| Feb 17, 2026 | TYRA | Tyra Biosciences, Inc. | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 2.1% | 1.1M |
| Feb 17, 2026 | PALI | PALISADE BIO, INC. | Point72 Asset Management, L.P. | 13G/A | 7.0% | 10.5M |
| Feb 17, 2026 | IDYA | IDEAYA Biosciences, Inc. | Point72 Asset Management, L.P. | 13G/A | 2.1% | 1.8M |
| Feb 17, 2026 | WHR | Whirlpool Corp | Appaloosa LP | 13G/A | 7.0% | 3.9M |
| Feb 17, 2026 | SVRA | Savara Inc. | TCG Crossover GP I, LLC | 13G/A | 6.1% | 12.4M |
| Feb 17, 2026 | ELDN | Eledon Pharmaceuticals, Inc. | RA Capital Management, L.P. | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | DSGN | Design Therapeutics, Inc. | Point72 Asset Management, L.P. | 13G/A | 9.4% | 5.4M |
| Feb 17, 2026 | TENX | TENAX THERAPEUTICS, INC. | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 7.8% | 596K |
| Feb 17, 2026 | RLYB | Rallybio Corporation | VIKING GLOBAL INVESTORS LP | 13G/A | 10.0% | 4.2M |
| Feb 17, 2026 | CRCL | Circle Internet Group, Inc. | General Catalyst Group Management Holdings GP, LLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | INBX | Inhibrx Biosciences, Inc. | VIKING GLOBAL INVESTORS LP | 13G/A | 10.0% | 1.5M |
| Feb 17, 2026 | WHLR | Wheeler Real Estate Investment Trust, Inc. | Magnetar Financial LLC | 13G/A | 9.8% | 206K |
| Feb 17, 2026 | PRMB | Primo Brands Corp | VIKING GLOBAL INVESTORS LP | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | CCOI | COGENT COMMUNICATIONS HOLDINGS, INC. | Turtle Creek Asset Management Inc. | 13G/A | 8.2% | 4.0M |
| Feb 17, 2026 | SAIA | SAIA INC | VIKING GLOBAL INVESTORS LP | 13G/A | 4.1% | 1.1M |
| Feb 17, 2026 | BFH | BREAD FINANCIAL HOLDINGS, INC. | Turtle Creek Asset Management Inc. | 13G/A | 5.6% | 2.6M |